Overview Nexium RESPONSE Trial Status: Completed Trial end date: 2007-11-01 Target enrollment: Participant gender: Summary The primary purpose of the study is to develop, and test, an algorithm for identification of responders to empirical esomeprazole treatment in general practices. Phase: Phase 4 Details Lead Sponsor: AstraZenecaTreatments: Esomeprazole